Published in Nat Genet on November 01, 1993
Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc Natl Acad Sci U S A (1994) 1.46
Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy. Nature (2011) 1.41
Genetic epidemiology of congenital muscular dystrophy in a sample from north-east Italy. Hum Genet (1996) 1.24
The congenital muscular dystrophies: recent advances and molecular insights. Pediatr Dev Pathol (2006) 1.09
The role of defective glycosylation in congenital muscular dystrophy. Glycoconj J (2004) 0.97
Assignment of the muscle-eye-brain disease gene to 1p32-p34 by linkage analysis and homozygosity mapping. Am J Hum Genet (1999) 0.94
A gene for autosomal recessive limb-girdle muscular dystrophy in Manitoba Hutterites maps to chromosome region 9q31-q33: evidence for another limb-girdle muscular dystrophy locus. Am J Hum Genet (1998) 0.94
Identification of a new locus for a peculiar form of congenital muscular dystrophy with early rigidity of the spine, on chromosome 1p35-36. Am J Hum Genet (1998) 0.93
Assignment of a form of congenital muscular dystrophy with secondary merosin deficiency to chromosome 1q42. Am J Hum Genet (2000) 0.88
Further evidence of Fukutin mutations as a cause of childhood onset limb-girdle muscular dystrophy without mental retardation. Neuromuscul Disord (2009) 0.87
Refined mapping of a gene responsible for Fukuyama-type congenital muscular dystrophy: evidence for strong linkage disequilibrium. Am J Hum Genet (1994) 0.87
Age and origin of the FCMD 3'-untranslated-region retrotransposal insertion mutation causing Fukuyama-type congenital muscular dystrophy in the Japanese population. Hum Genet (2000) 0.86
Founder Fukutin mutation causes Walker-Warburg syndrome in four Ashkenazi Jewish families. Prenat Diagn (2009) 0.85
Syndromes with lissencephaly. J Med Genet (1996) 0.83
Mislocalization of fukutin protein by disease-causing missense mutations can be rescued with treatments directed at folding amelioration. J Biol Chem (2012) 0.83
Brain alterations in the classical form of congenital muscular dystrophy. Clinical and neuroimaging follow-up of 12 cases and correlation with the expression of merosin in muscle. Childs Nerv Syst (1996) 0.82
Autosomal dominant cerebellar ataxia with retinal degeneration (ADCA II): clinical and neuropathological findings in two pedigrees and genetic linkage to 3p12-p21.1. J Neurol Neurosurg Psychiatry (1997) 0.81
Linkage-disequilibrium mapping narrows the Fukuyama-type congenital muscular dystrophy (FCMD) candidate region to <100 kb. Am J Hum Genet (1996) 0.80
Altered aquaporin 4 expression in muscles of Fukuyama-type congenital muscular dystrophy. Virchows Arch (2003) 0.78
Congenital muscular dystrophy and severe central nervous system atrophy in two siblings. Acta Neuropathol (1995) 0.75
Congenital muscular dystrophy with severe retrocollis and mental retardation: a report of two siblings. J Neurol Neurosurg Psychiatry (1997) 0.75
Congenital protein hypoglycosylation diseases. Appl Clin Genet (2012) 0.75
Investigation of muscle disease. J Neurol Neurosurg Psychiatry (1996) 0.75
A novel pattern of oculocerebral malformation. Br J Ophthalmol (1997) 0.75
Congenital muscular dystrophy: from muscle to brain. Ital J Pediatr (2016) 0.75
A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature (1990) 7.89
Complete sequence and gene organization of the genome of a hyper-thermophilic archaebacterium, Pyrococcus horikoshii OT3. DNA Res (1998) 6.79
Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature (2000) 5.71
Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature (1993) 4.33
A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell (1990) 3.97
An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature (1998) 3.86
Inter-mitochondrial complementation: Mitochondria-specific system preventing mice from expression of disease phenotypes by mutant mtDNA. Nat Med (2001) 3.81
Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy. Science (1995) 3.66
Discovery of a cool planet of 5.5 Earth masses through gravitational microlensing. Nature (2006) 3.53
Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet (1994) 3.39
Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature (1988) 3.25
Induction of various autoantibodies by mutant gene lpr in several strains of mice. J Immunol (1984) 3.20
Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet (1996) 3.07
Generation of mice with mitochondrial dysfunction by introducing mouse mtDNA carrying a deletion into zygotes. Nat Genet (2000) 3.06
Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc Natl Acad Sci U S A (1991) 3.00
MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. Proc Natl Acad Sci U S A (1992) 2.82
Endoscopic resection of early gastric cancer and other tumors with local injection of hypertonic saline-epinephrine. Gastrointest Endosc (1988) 2.68
Mutations in the integrin alpha7 gene cause congenital myopathy. Nat Genet (1998) 2.66
Distal myopathy with rimmed vacuoles is allelic to hereditary inclusion body myopathy. Neurology (2002) 2.66
Cloning and functional characterization of a novel ATP-sensitive potassium channel ubiquitously expressed in rat tissues, including pancreatic islets, pituitary, skeletal muscle, and heart. J Biol Chem (1995) 2.62
Pressure-controlled ventilation via a mini-tracheostomy tube for patients with neuromuscular disease. Neurology (2000) 2.58
Primary structures of human alpha-fetoprotein and its mRNA. Proc Natl Acad Sci U S A (1983) 2.49
Cell heterogeneity upon myogenic differentiation: down-regulation of MyoD and Myf-5 generates 'reserve cells'. J Cell Sci (1998) 2.43
Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod (2004) 2.35
Abnormal expression of dystrophin-associated proteins in Fukuyama-type congenital muscular dystrophy. Lancet (1993) 2.33
Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value. J Nucl Med (1999) 2.32
The presumptive CDR3 regions of both T cell receptor alpha and beta chains determine T cell specificity for myoglobin peptides. J Exp Med (1990) 2.32
Molecular cloning and characterization of rat estrogen receptor cDNA. Nucleic Acids Res (1987) 2.26
Studies in myoclonus epilepsy (Lafora body form). II. Polyglucosans in the systemic deposits of myoclonus epilepsy and in corpora amylacea. Neurology (1970) 2.21
Mosaic expression of dystrophin in symptomatic carriers of Duchenne's muscular dystrophy. N Engl J Med (1989) 2.19
A new ABC transporter mediating the detachment of lipid-modified proteins from membranes. Nat Cell Biol (2000) 2.16
Expression of adult and fetal natural killer cell markers in sinonasal lymphomas. Blood (1994) 2.16
Cloning and the nucleotide sequence of rat glutathione S-transferase P cDNA. Nucleic Acids Res (1985) 2.15
Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurol (1976) 2.14
New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology (2005) 2.14
Studies in myoclonus epilepsy (Lafora body form). I. Isolation and preliminary characterization of Lafora bodies in two cases. Arch Neurol (1968) 2.13
Discovery of a Jupiter/Saturn analog with gravitational microlensing. Science (2008) 2.09
Prevalence of anxiety, depression, and substance use disorders in an urban general medicine practice. Arch Fam Med (2000) 2.01
Loss of beta-catenin expression associated with disease progression in malignant melanoma. Br J Dermatol (2001) 2.00
Guidelines for reporting clinical features in cases with MECP2 mutations. Brain Dev (2001) 1.99
Emergency pulmonary embolectomy with percutaneous cardiopulmonary bypass. Ann Thorac Surg (1997) 1.95
Long-term outcome of endoscopic papillotomy for choledocholithiasis with cholecystolithiasis. Gastrointest Endosc (2000) 1.94
Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol (2000) 1.92
Structure and expression of a human class pi glutathione S-transferase messenger RNA. Cancer Res (1987) 1.91
Gallbladder torsion: case report. Abdom Imaging (2001) 1.86
Familial distal myopathy with rimmed vacuole and lamellar (myeloid) body formation. J Neurol Sci (1981) 1.86
Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology (1992) 1.85
Scavenging effects of tea catechins and their derivatives on 1,1-diphenyl-2-picrylhydrazyl radical. Free Radic Biol Med (1996) 1.82
Evaluation of the therapeutic effect of radiotherapy on cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys (1999) 1.82
Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations. Ann Neurol (2000) 1.82
Complete sequence and gene organization of the genome of a hyper-thermophilic archaebacterium, Pyrococcus horikoshii OT3 (supplement). DNA Res (1998) 1.81
Prognostic value of tumor-associated macrophage count in human bladder cancer. Int J Urol (2000) 1.81
A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study. Arch Ophthalmol (1996) 1.80
Ototoxicity of neomycin and its penetration through the round window membrane into the perilymph. Ann Otol Rhinol Laryngol (1986) 1.80
Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology (1996) 1.78
Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. Br J Cancer (2001) 1.77
alpha1-syntrophin gene disruption results in the absence of neuronal-type nitric-oxide synthase at the sarcolemma but does not induce muscle degeneration. J Biol Chem (1999) 1.75
Crystal structure of the macrophage migration inhibitory factor from rat liver. Nat Struct Biol (1996) 1.75
Intracranial penetrating injuries via the optic canal. AJNR Am J Neuroradiol (1998) 1.74
Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy. Ann Neurol (1994) 1.73
Spectrum of CT findings in nonmalignant disease of the adrenal gland. Radiographics (1998) 1.71
Ornithine decarboxylase overexpression in mouse 10T1/2 fibroblasts: cellular transformation and invasion. J Natl Cancer Inst (1997) 1.68
Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies. J Cell Sci (1997) 1.68
Laminin alpha2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy. FEBS Lett (1997) 1.67
Immunohistochemical characterization of cerebrovascular amyloid in 46 autopsied cases using antibodies to beta protein and cystatin C. Stroke (1990) 1.67
Nemaline myopathy: comparative muscle histochemistry in the severe neonatal, moderate congenital, and adult-onset forms. Pediatr Neurol (1989) 1.66
Point mutations in mitochondrial tRNA genes: sequence analysis of chronic progressive external ophthalmoplegia (CPEO) J Neurol Sci (1994) 1.65
Medial prefrontal cortex generates frontal midline theta rhythm. Neuroreport (1999) 1.64
Cloning and determination of the transcription termination site of ribosomal RNA gene of the mouse. Nucleic Acids Res (1982) 1.64
Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthritis Cartilage (2006) 1.64
The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. Hum Mol Genet (2001) 1.63
Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095. Br J Pharmacol (2001) 1.61
A novel WD40 protein, CHE-2, acts cell-autonomously in the formation of C. elegans sensory cilia. Development (1999) 1.61
Correlation of the antibody titers with serum prolactin levels and their clinical course in patients with anti-prolactin autoantibody. Eur J Endocrinol (1994) 1.59
The frequency of patients with dystrophin abnormalities in a limb-girdle patient population. Neurology (1991) 1.59
Autoimmune pancreatitis: CT and MR characteristics. AJR Am J Roentgenol (1998) 1.55
Cerebrovascular responsiveness to hypercapnia in Alzheimer's dementia and vascular dementia of the Binswanger type. Stroke (1992) 1.54
Congenital neuromuscular disease with uniform type 1 fiber and RYR1 mutation. Neurology (2007) 1.53
Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies. Rheumatology (Oxford) (2008) 1.53
Human mitochondria and mitochondrial genome function as a single dynamic cellular unit. J Cell Biol (1994) 1.53
Caveolin-3 deficiency causes muscle degeneration in mice. Hum Mol Genet (2000) 1.53
Clinicopathological features of genetically confirmed Danon disease. Neurology (2002) 1.51
Risk factors for recurrent bile duct stones after endoscopic papillotomy. Gut (2003) 1.50
UNC-4/UNC-37-dependent repression of motor neuron-specific genes controls synaptic choice in Caenorhabditis elegans. Genes Dev (1999) 1.50
Molecular analysis of external genitalia formation: the role of fibroblast growth factor (Fgf) genes during genital tubercle formation. Development (2000) 1.50
HLA-DR8 and acute anterior uveitis in ankylosing spondylitis. Arthritis Rheum (1995) 1.49
Maternal inheritance of deleted mitochondrial DNA in a family with mitochondrial myopathy. Biochem Biophys Res Commun (1988) 1.48
Myoclonus epilepsy associated with ragged-red fibers: a G-to-A mutation at nucleotide pair 8363 in mitochondrial tRNA(Lys) in two families. Muscle Nerve (1997) 1.47
A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Biochim Biophys Acta (1991) 1.46
Differential diagnosis between thymoma and non-thymoma by dynamic MR imaging. Acta Radiol (2002) 1.46